Stanley J. Musial joined EryDel S.p.A. as its Chief Financial Officer in November 2018. Before joining EryDel, Stan held the position of Executive Vice President and Chief Financial Officer of Egalet (NASDAQ: EGLT), a commercial stage, fully integrated specialty pharmaceutical company focused on innovative treatments for pain, from 2014 to 2018. Stan took Egalet public in 2014, and was part of a team that transformed the company from development stage to revenue generation. Prior to Egalet, Stan held the position of Chief Financial Officer at Prism Pharmaceuticals, Inc., Strategic Diagnostics, Inc., and positions with other biotechnology, medical device and healthcare services companies. Mr. Musial began his career with KPMG LLP, a professional services company, and received a B.S. in accounting from the Pennsylvania State University and an M.B.A. from Temple University. He is a certified public accountant in the Commonwealth of Pennsylvania.